๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
Trackers Drugs Comparisons API
Trackers› Clinical trials› Cork
Clinical trial register · Ireland

Clinical Trials in Cork

Every study on the ClinicalTrials.gov registry that lists a site in Ireland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Alert me on this filter Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 615 matching records held by the registry are in this view. Synced 22 Sep 2026, 03:15 UTC
615
Studies in scope
all four open statuses
323
Recruiting now
open to new participants
181
Lead sponsors
across recruiting studies
7
Irish site locations
across all listed studies
Phase mix of the 323 recruiting studies
Phase 3 98 Not applicable 79 Observational 76 Phase 2 30 Phase 1/2 20 Other 20
Narrow the register Reset
Matches title, registry number, sponsor, intervention and condition.
Recruitment status
Phase
Lead sponsor
University College Cork 18 Merck Sharp & Dohme LLC 16 Cancer Trials Ireland 8 AbbVie 7 AstraZeneca 7 Clear sponsor filter
Site location
Dublin 10 Cork 7 Galway 3 Waterford 2 Ballinasloe 1
All 7 locations
Target enrolment
to
7 of 615 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Irish sites
Start
Recruiting
AZD5335 vs. Mirvetuximab Soravtansine in FRฮฑ-high and AZD5335 vs. Chemotherapy in FRฮฑ-low Platinum-resistant Ovarian Cancer
NCT07218809 Epithelial Ovarian Cancer
AstraZeneca
Phase 3
1,100
Cork, Dublin, Waterford
2025-12-29
Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
NCT06868277 Carcinoma, Non-Small Cell Lung
AstraZeneca
Phase 3
830
Cork, Dublin, Galway
2025-04-10
Recruiting
Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment
NCT06750289 Eosinophilic Asthma
AstraZeneca
Phase 3
400
Ballinasloe, Cork, Dublin, Moneymore
2025-03-28
Active, closed
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
NCT05952557 Breast Cancer, Early Breast Cancer
AstraZeneca
Phase 3
5,511
Cork, Dublin, Galway, Waterford
2023-10-05
Active, closed
A Phase III Study of Ceralasertib Plus Durvalumab Versus Docetaxel in Patients With Non Small Cell Lung Cancer (NSCLC) Whose Disease Progressed On or After Prior Anti PD (L)1 Therapy And Platinum Based Chemotherapy
NCT05450692 Advanced or Metastatic Non-Small Cell Lung Cancer
AstraZeneca
Phase 3
594
Cork, Dublin, Limerick
2022-09-15
Active, closed
A Study of T-DXd in Participants With or Without Brain Metastasis Who Have Previously Treated Advanced or Metastatic HER2 Positive Breast Cancer
NCT04739761 Breast Cancer
AstraZeneca
Phase 3
506
Cork, Dublin
2021-06-22
Active, closed
To Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus Olaparib Monotherapy.
NCT03330847 Metastatic Triple Negative Breast Cancer
AstraZeneca
Phase 2
273
Cork, Dublin
2018-03-07
Rows per page Showing 1–7 of 7
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Irish investigative site, filtered. Derived from ClinicalTrials.gov, U.S. National Library of Medicine. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-ireland/city/cork

Query this register directly
GET /api/trials?country=ie&status=recruiting&phase=Phase+3&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. For trials across the wider EU, see the EU Clinical Trials Tracker.